Organic Process Research & Development · 2012 · 63 citations · 13 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologySynthetic Medicinal ChemistryEnzyme InhibitionHigh-throughput SynthesisTyrosine Kinase InhibitorsChemoselective SynthesisContinuous ProcessingFragment Coupling StrategyHalogen Exchange ReactionsMedicinal Chemistry ApplicationsMild Reaction ConditionsReaction Yield ImprovementScale-up Synthesis
The development of a convergent, chromatography-free synthesis of an allosteric Akt kinase inhibitor is described. The route comprised 17 total steps and was used to produce kilogram quantities of the target molecule. A key early transformation, for which both batch and flow protocols were developed, was formylation of a dianion derived by deprotonation and subsequent lithium-halogen exchange from a 2-bromo-3-aminopyridine precursor. Improved reaction yield and practicality were achieved in the continuous processing mode. Further significant process developments included the safe execution of a high temperature and pressure hydrazine displacement, separation of substituted cyclobutane diastereomers by means of chemoselective ester hydrolysis, and a late-stage Suzuki fragment coupling under mild conditions.
13
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Spencer D. Dreher, Peter G. Dormer, Deidre L. Sandrock et al. · Journal of the American Chemical Society · 2008 · 262 citations · Full text
Wei Shu, Laurent Pellegatti, Matthias A. Oberli et al. · Angewandte Chemie International Edition · 2011 · 113 citations · Full text